Lv11
50 积分 2025-06-28 加入
Remibrutinib in Chronic Spontaneous Urticaria
2小时前
待确认
Targeted protein degradation for cancer therapy
3天前
已完结
A guide to complement biology, pathology and therapeutic opportunity
5天前
已完结
Safety and Efficacy of Avacopan in Patients with Complement 3 Glomerulopathy: Randomized, Double-Blind Clinical Trial
9天前
已完结
Functional assessment of all ATM SNVs using prime editing and deep learning
3个月前
已完结
Phase Ib basket expansion trial and alternative-schedule dose-escalation study of ATR inhibitor elimusertib in advanced solid tumors with DNA damage response defects
4个月前
已完结
皖公网安备34019202002308
